Defining a Stromal Signature that Facilitates Progression of Lethal Cancers

定义促进致命癌症进展的基质特征

基本信息

项目摘要

Project Summary/Abstract The activity proposed in this Research Specialist Award application is in line with the long-standing goals of Dr. Thea Tlsty (the Unit Director)'s currently NCI-funded research program which currently supports my activity/effort: i) understand dynamic mechanisms underlying cellular plasticity and tissue response to stress; and ii) explore the role of tissue microenvironment and how these multiple factors contribute to tumor initiation and progression. These efforts are particularly worthwhile when dealing with the most lethal type of breast cancer, metaplastic breast cancers (MBCs). Identifying tissue components and signaling pathways that contribute to the emergence of these cancers in order to design more successful therapies for patients diagnosed with MBCs is indeed of the outmost clinical relevance. This application is the result of my personal ‘twist’ on the long-term interest of the Tlsty laboratory on the role of stromal-epithelial interactions in breast tumorigenesis. Its core concept relies on the increasingly appreciated notion that cancer progression requires an instructive tumor microenvironment (TME). Generation of a TME results from: acquisition of a cancer- associated fibroblast signature, a shift in macrophage type, alterations of ECM characteristics that either facilitate or counteract tumor growth, a corrupted immune response, an expanded and leaky vasculature and as a correlate an hypoxic environment and increased epithelial cell plasticity. Such phenotypes are exemplified in aggressive tumors characterized by a desmoplastic stroma with extensive and altered ECM deposition typified by MBCs. Thus, the imbalance in ECM composition seen in MBCs is the result of extensive structural and functional stromal changes that result from alterations in both stromal and epithelial cell properties. Our provocative prediction that a specific ECM/stromal make-up may identify cancers with the poorest outcome across breast cancer subtypes (luminal, Her2-positive, basal-like) may be of high clinical relevance not only for MBCs and basal-like cancers, but also for luminal breast cancers with late recurrence. To gain valuable insights, I will: i) identify stromal drivers (and repressors) of progression of MBCs through comparative proteomic analysis of ECM from breast tumor (including MBC) and disease-free breast specimens with an emphasis on post-translational modification status; ii) interrogate gene expression databases for upregulation (or down-regulation) of these ECM proteins across breast cancer subtypes (luminal, Her2-positive, basal, claudin low) through data mining; iii) test the ability of some of these ECM proteins to drive (or repress) cell plasticity (multilineage commitment and epithelial mesenchymal transition) in vitro using 3D cell culture models; and iv) confirm in vivo the pro- (or anti-)metaplastic/tumorigenic activity of these ECM proteins in murine xenograft models. My extensive experience in protein biochemistry, cell biology and characterization of mouse models combined with my recent interest in data mining and multiplex immunohistochemistry, place me in an optimal position for the novel pursuit of ECM alterations underlying progression of MBCs.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PHILIPPE GASCARD其他文献

PHILIPPE GASCARD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PHILIPPE GASCARD', 18)}}的其他基金

Defining a Stromal Signature that Facilitates Progression of Lethal Cancers
定义促进致命癌症进展的基质特征
  • 批准号:
    10017900
  • 财政年份:
    2019
  • 资助金额:
    $ 24.7万
  • 项目类别:
Defining a Stromal Signature that Facilitates Progression of Lethal Cancers
定义促进致命癌症进展的基质特征
  • 批准号:
    10469340
  • 财政年份:
    2019
  • 资助金额:
    $ 24.7万
  • 项目类别:
RED CELL CYTOSKELETON PROTEIN 4.1R IN KIDNEY FUNCTION
红细胞细胞骨架蛋白 4.1R 在肾功能中的作用
  • 批准号:
    6517652
  • 财政年份:
    2000
  • 资助金额:
    $ 24.7万
  • 项目类别:
RED CELL CYTOSKELETON PROTEIN 4.1R IN KIDNEY FUNCTION
红细胞细胞骨架蛋白 4.1R 在肾功能中的作用
  • 批准号:
    6737562
  • 财政年份:
    2000
  • 资助金额:
    $ 24.7万
  • 项目类别:
RED CELL CYTOSKELETON PROTEIN 4.1R IN KIDNEY FUNCTION
红细胞细胞骨架蛋白 4.1R 在肾功能中的作用
  • 批准号:
    6381635
  • 财政年份:
    2000
  • 资助金额:
    $ 24.7万
  • 项目类别:
RED CELL CYTOSKELETON PROTEIN 4.1R IN KIDNEY FUNCTION
红细胞细胞骨架蛋白 4.1R 在肾功能中的作用
  • 批准号:
    6130857
  • 财政年份:
    2000
  • 资助金额:
    $ 24.7万
  • 项目类别:
RED CELL CYTOSKELETON PROTEIN 4.1R IN KIDNEY FUNCTION
红细胞细胞骨架蛋白 4.1R 在肾功能中的作用
  • 批准号:
    6635191
  • 财政年份:
    2000
  • 资助金额:
    $ 24.7万
  • 项目类别:

相似海外基金

Open Access Block Award 2024 - Durham University
2024 年开放访问区块奖 - 杜伦大学
  • 批准号:
    EP/Z531480/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.7万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - Goldsmiths College
2024 年开放获取区块奖 - 金史密斯学院
  • 批准号:
    EP/Z531509/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.7万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - John Innes Centre
2024 年开放访问区块奖 - 约翰·英尼斯中心
  • 批准号:
    EP/Z53156X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.7万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - London School of Economics & Pol Sci
2024 年开放获取区块奖 - 伦敦政治经济学院
  • 批准号:
    EP/Z531625/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.7万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - Oxford Brookes University
2024 年开放获取区块奖 - 牛津布鲁克斯大学
  • 批准号:
    EP/Z531728/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.7万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - The Francis Crick Institute
2024 年开放获取区块奖 - 弗朗西斯·克里克研究所
  • 批准号:
    EP/Z531844/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.7万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - The Natural History Museum
2024 年开放访问区块奖 - 自然历史博物馆
  • 批准号:
    EP/Z531856/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.7万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - University of Brighton
2024 年开放获取区块奖 - 布莱顿大学
  • 批准号:
    EP/Z531935/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.7万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - University of Bristol
2024 年开放获取区块奖 - 布里斯托大学
  • 批准号:
    EP/Z531947/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.7万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - University of Bradford
2024 年开放获取区块奖 - 布拉德福德大学
  • 批准号:
    EP/Z531923/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.7万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了